Skip to main content
Clinical Trials/CTRI/2024/07/070838
CTRI/2024/07/070838
Not yet recruiting
Phase 4

A Comparative study to evaluate the efficacy and safety of Bempedoic acid versus Ezetimibe in patients with Dyslipidemia - NI

Afzal Noor0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Afzal Noor
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Afzal Noor

Eligibility Criteria

Inclusion Criteria

  • Stable atherosclerotic cardiovascular disease
  • Uncontrolled LDL cholesterol level (fasting more than 70 mg/dl) on maximally tolerated dose of statin.(Atrovastatin 80 mg OD, Rosuvastatin 40 mg OD)

Exclusion Criteria

  • Age less than 18 yr
  • BMI more or equal 40 kg/m sq.
  • Triglyceride levels more or equal to 500 mg/dl
  • History of statin intolerance
  • History of cardiac event in last 12 weeks
  • Pregnant and Lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials